News
FDA says it will phase out animal testing requirement for monoclonal antibodies and drugs
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there are “more effective,
FDA plans to phase out animal testing in drugs in what it calls a ‘paradigm shift’
On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued its announcement.
The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug ...
Pharmaceutical Technology on MSN2d
FDA approves injectable antibiotics for B Braun drug delivery systemThe US Food and Drug Administration (FDA) has approved the injectable antibiotics Piperacillin and Tazobactam for use in B ...
Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
CNN on MSN10d
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearanceThe US Food and Drug Administration has delayed ... “As of Tuesday, April 1, we had responded to all of the FDA’s ...
HealthDay on MSN5d
FDA Delays Final Approval of Novavax COVID VaccineThe decision had been expected by April 1, but the agency now says it needs more information before moving forward.
The Supreme Court backed the FDA's refusal to authorize the sale of kid-friendly flavored vapes, including the flavors ...
The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback